Brian Lum alias The Panel Chiropractor
consulting from the wellness trough at Functional Medicine Doctor
Website · drbrianlum.com
Practice location
18122 West 119th Street
Olathe, KS 66061
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 43 health claims, 8 run counter to or conflict with the published evidence, and 33 were not independently checked.
- Primary persuasion tactic: Chronic-illness scare-to-consult funnel.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend.
- Gives advice beyond what their license covers.
Brian Lum is the kind of doc bro who takes a chiropractic license, wraps it in IFM glitter, and then starts talking like the basement door to internal medicine finally opened. He sells the comforting fantasy that every fatigue, mood swing, thyroid wobble, and autoimmune flare has a premium panel with your name on it.
High grift signals
Score breakdown
Direct answer
Dr. Brian Lum is reviewed as a chiropractor (DC), not an MD/DO physician. Dr. Trust Me Bro analyzed Dr. Brian Lum's claim that "Crohn's and ulcerative colitis" using transcript and metadata cross-checked against academic sources. Peer-reviewed literature indicates the claim is mixed in the medical literature: Because the influencer’s claim is unspecified and only mentions “Crohn’s and ulcerative colitis,” the closest evidence-based interpretation is that they may be discussing: 1) that Crohn’s disease and ulcerative colitis are chronic inflammatory bowel diseases, and/or 2) that they are treatable with a range of medical therapies including biologics, immunomodulators, and adjunctive agents. High‑quality systematic reviews, network meta‑analyses, and guidelines strongly support that Crohn’s disease and ulcerative colitis are distinct but related forms of inflammatory bowel disease characterized by chronic intestinal inflammation, relapsing–remitting course, and need for long‑term management.[11][15] Multiple network meta‑analyses show that biologic and small‑molecule therapies (e.g., anti‑TNF agents, anti‑integrin agents, JAK inhibitors, S1P modulators) are effective in inducing and maintaining remission in moderate‑to‑severe ulcerative colitis, supporting the concept that UC is a serious but highly treatable chronic disease.[0][13][6][7][10] Infliximab is specifically supported by systematic reviews and meta‑analyses as an effective advanced therapy in moderate–severe UC and as rescue therapy in severe steroid‑refractory UC, underscoring the role of targeted biologics in ulcerative colitis management.[2][7][8][13] Thiopurines such as azathioprine and mercaptopurine have evidence from systematic review and meta‑analysis showing benefit as maintenance therapy in ulcerative colitis, aligning with guideline recommendations to use them as steroid‑sparing maintenance agents in selected patients.[3] Probiotic therapy with Escherichia coli Nissle 1917 has systematic‑review evidence suggesting it can be comparable to mesalazine for preventing relapse in quiescent UC, supporting the idea that microbiome‑modulating strategies can play a supplemental role in UC management, although not as primary induction therapy.[5] Systematic reviews and guidelines emphasize risk stratification (e.g., clinical predictors of colectomy, severity at presentation) and stepwise escalation to immunomodulators, biologics, or surgery, which supports the framing of Crohn’s and ulcerative colitis as chronic, medically manageable conditions that sometimes require surgery.[4][11][16][19][20] Because the influencer’s claim is not specified beyond naming “Crohn’s and ulcerative colitis,” it is impossible to identify a precise proposition to contradict; however, several common misinformation themes about these diseases are inconsistent with the high‑quality evidence base. Evidence contradicts any implication that ulcerative colitis or Crohn’s disease are easily cured conditions: systematic reviews and guidelines consistently describe them as chronic, relapsing inflammatory bowel diseases that typically require ongoing surveillance and maintenance therapy rather than a one‑time cure.[11][15][19][20] Meta‑analyses of rescue therapies such as infliximab or ciclosporin in steroid‑refractory severe UC show that while these agents can avoid immediate colectomy in a proportion of patients, many still progress to surgery or relapse, contradicting any claim that a single medication can definitively cure severe UC.[2][4] The evidence on Escherichia coli Nissle 1917 shows it is roughly equivalent to mesalazine for maintenance in quiescent UC but not clearly superior and not clearly effective as an induction therapy, which contradicts any claim that this probiotic alone can reliably induce remission or replace standard anti‑inflammatory or biologic therapies.[5][1] Placebo response rates in UC clinical trials are substantial but clearly lower than response rates to active advanced therapies; systematic reviews and network meta‑analyses show that biologics and small molecules significantly outperform placebo for induction and maintenance endpoints, contradicting narratives that advanced therapies are no better than placebo or purely driven by placebo effect.[6][7][10][13] Evidence-based guidelines also contradict claims that diet or supplements alone can fully treat moderate‑to‑severe Crohn’s disease or ulcerative colitis; while diet, probiotics, and lifestyle factors can be adjunctive, guidelines place primary emphasis on established pharmacologic therapies (5‑ASA for mild UC, corticosteroids for flares, immunomodulators, biologics, and small molecules for moderate‑to‑severe disease).[11][12][19][20] Mainstream medical and scientific consensus is that Crohn’s disease and ulcerative colitis are the two main forms of inflammatory bowel disease, characterized by chronic, immune‑mediated inflammation of the gastrointestinal tract Often searched as Dr Brian Lum.
Key findings
- Sales Funnel Motive: The page opens with chronic illness, mystery symptoms, and poor conventional care, then routes people into remote consults, testing, and custom treatment plans. That is classic attention capture feeding a paid intake funnel.see section ↓
- Claim "Crohn's and ulcerative colitis": mixed in the medical literature.see section ↓
- Claim "Autoimmune Disease": not supported by peer-reviewed evidence.see section ↓
- NPI registry confirms Brian Lum as Chiropractor (DC) in Kansas (NPI 1639421845).see section ↓
- Dr. Brian Lum shows credential inflation relative to stated vs likely credentials.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. §65-2871 (Kansas Healing Arts Act)), these advertised activities appear outside Dr. Brian Lum's license (including conditions they merely list as ones they treat): Crohn's and ulcerative colitis, Autoimmune disease,…see section ↓
- 24 of 24 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
- Dr. Brian Lum dispenses specific medical advice while hiding behind a buried fine-print disclaimer to shield advice that is itself outside their licensed scope.see section ↓
Claims & evidence
22 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Crohn's and ulcerative colitis.
Crohn's and ulcerative colitis
- Supports
- Because the influencer’s claim is unspecified and only mentions “Crohn’s and ulcerative colitis,” the closest evidence-based interpretation is that they may be discussing: 1) that Crohn’s disease and ulcerative colitis are chronic inflammatory bowel diseases, and/or 2) that they are treatable with a range of medical therapies including biologics, immunomodulators, and adjunctive agents. High‑quality systematic reviews, network meta‑analyses, and guidelines strongly support that Crohn’s disease and ulcerative colitis are distinct but related forms of inflammatory bowel disease characterized by chronic intestinal inflammation, relapsing–remitting course, and need for long‑term management.[11][15] Multiple network meta‑analyses show that biologic and small‑molecule therapies (e.g., anti‑TNF agents, anti‑integrin agents, JAK inhibitors, S1P modulators) are effective in inducing and maintaining remission in moderate‑to‑severe ulcerative colitis, supporting the concept that UC is a serious but highly treatable chronic disease.[0][13][6][7][10] Infliximab is specifically supported by systematic reviews and meta‑analyses as an effective advanced therapy in moderate–severe UC and as rescue therapy in severe steroid‑refractory UC, underscoring the role of targeted biologics in ulcerative colitis management.[2][7][8][13] Thiopurines such as azathioprine and mercaptopurine have evidence from systematic review and meta‑analysis showing benefit as maintenance therapy in ulcerative colitis, aligning with guideline recommendations to use them as steroid‑sparing maintenance agents in selected patients.[3] Probiotic therapy with Escherichia coli Nissle 1917 has systematic‑review evidence suggesting it can be comparable to mesalazine for preventing relapse in quiescent UC, supporting the idea that microbiome‑modulating strategies can play a supplemental role in UC management, although not as primary induction therapy.[5] Systematic reviews and guidelines emphasize risk stratification (e.g., clinical predictors of colectomy, severity at presentation) and stepwise escalation to immunomodulators, biologics, or surgery, which supports the framing of Crohn’s and ulcerative colitis as chronic, medically manageable conditions that sometimes require surgery.[4][11][16][19][20]
- Contradicts
- Because the influencer’s claim is not specified beyond naming “Crohn’s and ulcerative colitis,” it is impossible to identify a precise proposition to contradict; however, several common misinformation themes about these diseases are inconsistent with the high‑quality evidence base. Evidence contradicts any implication that ulcerative colitis or Crohn’s disease are easily cured conditions: systematic reviews and guidelines consistently describe them as chronic, relapsing inflammatory bowel diseases that typically require ongoing surveillance and maintenance therapy rather than a one‑time cure.[11][15][19][20] Meta‑analyses of rescue therapies such as infliximab or ciclosporin in steroid‑refractory severe UC show that while these agents can avoid immediate colectomy in a proportion of patients, many still progress to surgery or relapse, contradicting any claim that a single medication can definitively cure severe UC.[2][4] The evidence on Escherichia coli Nissle 1917 shows it is roughly equivalent to mesalazine for maintenance in quiescent UC but not clearly superior and not clearly effective as an induction therapy, which contradicts any claim that this probiotic alone can reliably induce remission or replace standard anti‑inflammatory or biologic therapies.[5][1] Placebo response rates in UC clinical trials are substantial but clearly lower than response rates to active advanced therapies; systematic reviews and network meta‑analyses show that biologics and small molecules significantly outperform placebo for induction and maintenance endpoints, contradicting narratives that advanced therapies are no better than placebo or purely driven by placebo effect.[6][7][10][13] Evidence-based guidelines also contradict claims that diet or supplements alone can fully treat moderate‑to‑severe Crohn’s disease or ulcerative colitis; while diet, probiotics, and lifestyle factors can be adjunctive, guidelines place primary emphasis on established pharmacologic therapies (5‑ASA for mild UC, corticosteroids for flares, immunomodulators, biologics, and small molecules for moderate‑to‑severe disease).[11][12][19][20]
“CROHN'S AND ULCERATIVE COLITIS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Autoimmune disease.
Autoimmune disease
- Supports
- No high-quality evidence in the provided index papers supports the standalone claim "Autoimmune Disease" because the indexed items are unrelated to autoimmune disease as a causal or diagnostic assertion. The only autoimmune-related indexed item is a review/decision record for a meta-analysis on parental autoimmune diseases and offspring allergic disease, but the index list does not include the actual peer-reviewed meta-analysis results, so it cannot be used to support the influencer’s claim directly. [5]
- Contradicts
- The claim is too vague to assess as written and does not make a testable medical statement. The provided index papers do not address autoimmune disease generally, and one indexed guideline concerns community-acquired pneumonia, which is unrelated to autoimmune disease . [5] Because the listed sources are not the underlying autoimmune meta-analysis but only editorial/review records, they provide no substantive evidentiary support for a broad autoimmune-disease claim.
- Mainstream view
- Autoimmune disease is a broad category of conditions in which the immune system targets the body’s own tissues; assessing any specific influencer claim requires a precise statement about a disease, mechanism, risk factor, or treatment. As written, the claim is not specific enough for evidence-based validation, and the supplied sources do not establish or refute any particular autoimmune-disease claim. [5]
“AUTOIMMUNE DISEASE”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Heart disease.
Heart disease
- Supports
- The provided index papers do not directly support the broad claim “Heart disease,” because most are either about unrelated topics or about specific interventions rather than a general statement about heart disease. The only potentially relevant items are a systematic review/meta-analysis of mindfulness-based interventions in patients with coronary heart disease and a protocol concerning ivabradine in coronary artery disease and/or heart failure, but a protocol does not provide outcome evidence, and the review listing alone does not establish a general claim about heart disease .
- Contradicts
- The claim is too vague to be evidence-based as stated, and the index set does not contain a clear, directly relevant primary result supporting a broad assertion about heart disease. Several listed papers are unrelated to heart disease, including a trial protocol on choledocholithiasis and SGLT2 observational review entries that do not, from the index alone, establish the influencer’s claim .
- Mainstream view
- Mainstream medical science recognizes heart disease as a major category of cardiovascular disorders with many causes, presentations, and treatments, but a bare claim of “Heart disease” is not a substantive medical assertion and cannot be validated without specifics. In general, evidence-based guidance depends on the exact subtype, risk factor, symptom, or intervention being claimed, and the provided index papers are insufficient to support a broad claim. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“HEART DISEASE”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Lyme and coinfections.
Lyme and coinfections
- Supports
- There is strong evidence that Lyme disease can be accompanied by biologically plausible tick‑borne coinfections, particularly Babesia microti, Anaplasma phagocytophilum, and other pathogens transmitted by Ixodes ticks. Reviews on coinfections acquired from Ixodes ticks show that Borrelia burgdorferi (Lyme), Anaplasma, and Babesia frequently coexist in the same vector and can cause human coinfections, with coinfection in vertebrates reported up to around two‑thirds in some series and higher‑than‑expected odds of dual infection.[16][21] Epidemiologic studies in endemic areas (e.g., Connecticut and New York) demonstrate that persons with serologic evidence of Lyme disease have significantly higher Babesia seropositivity than general outpatients, supporting that Lyme and Babesia coinfection occurs and is clinically relevant.[6][24] Meta-analytic and review data on Borrelia–Anaplasma coinfection similarly confirm that coinfection and coexposure in humans and ticks are not rare, with combined odds ratios >1 for coinfection and observed prevalence much higher than predicted by chance alone.[16] Clinical reviews and cohort studies of Lyme patients also describe that coinfections—especially Babesia and Bartonella—are commonly suspected in clinical practice and may be associated with more severe or complex symptom profiles.[2][13][17][21] The occupational Lyme disease systematic review further supports that people with high tick exposure (outdoor workers) have high Borrelia seroprevalence, implying that coinfections in this population are biologically plausible though not directly quantified.
- Contradicts
- High-quality evidence does not support broad claims of widespread, chronic, atypical tick‑borne coinfections in patients with chronic, nonspecific illnesses, especially when these diagnoses are based on nonstandard testing or when typical objective features of infection are absent. A systematic review specifically examining chronic coinfections concluded that the medical literature did not demonstrate convincing evidence for chronic anaplasmosis, chronic babesiosis in immunocompetent persons without fever, lab abnormalities, or detectable parasitemia, tick‑borne transmission of Bartonella, or simultaneous Lyme and Bartonella infection, and therefore does not support diagnoses of chronic, atypical tick‑borne coinfections in such patients.[11][1] Population-based studies of early Lyme disease in endemic regions show that most patients with culture‑confirmed Lyme have no serologic evidence of other tick‑borne infections; for example, a New York study found Babesia microti co-infection in only a small minority of patients, with nearly 90% showing no evidence of any co-infection.[24] Other clinical series of erythema migrans–positive Lyme patients report co‑infection rates in single digits, substantially lower than some non‑probability samples or commercial lab data often cited by influencers.[23][24] Thus, while co‑infection does occur, mainstream evidence contradicts claims that the vast majority of Lyme patients have multiple chronic co‑infections or that these are a primary explanation for persistent nonspecific symptoms, especially in the absence of objective signs of ongoing infection.[11]
- Mainstream view
- Mainstream infectious disease practice and major guideline positions can be summarized as follows: Coinfection with other Ixodes‑borne pathogens (particularly Babesia microti and Anaplasma phagocytophilum) is recognized and should be considered in patients with Lyme disease who have atypically severe or persistent acute symptoms, cytopenias, hemolysis, high fevers, or laboratory features suggestive of another tick‑borne illness. Epidemiologic and clinical data support that such coinfections occur but are generally uncommon in typical early Lyme cohorts, and their prevalence is highly dependent on geography and local tick ecology.[7][16][21][24] Standard guidelines recommend targeted diagnostic evaluation for Babesia and Anaplasma in appropriate clinical scenarios and treatment with evidence‑based, finite antimicrobial regimens when coinfection is confirmed. At the same time, high‑quality systematic reviews emphasize that current peer‑reviewed literature does not substantiate diagnoses of chronic, atypical tick‑borne coinfections (e.g., chronic Babesia or Bartonella infection transmitted by ticks) as an explanation for chronic nonspecific symptoms years after treated Lyme in immunocompetent patients.[11][1] The mainstream view therefore acknowledges real, acute coinfection risk in endemic areas and high‑exposure populations, but rejects broad, unvalidated constructs of pervasive chronic polymicrobial tick‑borne infection as currently unsupported by robust evidence.[11][16]
“LYME AND COINFECTIONS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Mold illness/exposure.
Mold illness/exposure
- Supports
- High-quality evidence supports that persistent indoor dampness and visible mold are associated with increased respiratory and allergic outcomes, including asthma symptoms, cough, wheeze, respiratory infections, and allergic rhinitis; WHO states these are the most important health effects of dampness and mold exposure, and recommends preventing or minimizing persistent dampness and microbial growth. [14][15][16][17] Systematic reviews and meta-analyses also support an association with asthma development and respiratory tract infections, with effect sizes generally in the weak-to-moderate range. The peer-reviewed review literature and major guidelines consistently support mold exposure as a real health risk mainly for respiratory and allergic disease.
- Contradicts
- The evidence does not support broad claims that “mold illness” explains many nonspecific, systemic, neurologic, or chronic multisystem symptoms in a proven causal way; major reviews and guidelines focus on respiratory and allergic outcomes rather than a general toxic syndrome. [14][15][16] The evidence base is limited by observational designs, residual confounding, and imprecise exposure assessment, and some associations are described as causal only cautiously or as insufficient for firm causal attribution. [17] The index papers provided are unrelated to mold exposure and do not support the claim.
- Mainstream view
- Mainstream medicine recognizes indoor dampness and mold as a meaningful environmental health problem, especially for asthma, allergy, cough, wheeze, and respiratory infections, and recommends remediation of damp buildings; however, it does not accept a broad, validated “mold illness” diagnosis for most systemic or nonspecific symptoms without specific allergic, infectious, or irritant mechanisms. [14][15][16][17][12][13]
“MOLD ILLNESS/EXPOSURE”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Thyroid conditions.
Thyroid conditions
No specific health claims of theirs were cross-checked against the literature.
“THYROID CONDITIONS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Depression.
Depression
No specific health claims of theirs were cross-checked against the literature.
“DEPRESSION”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure PANS & PANDAS.
PANS & PANDAS
No specific health claims of theirs were cross-checked against the literature.
“PANS & PANDAS - An Integrative Approach”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Infertility, Prenatal Care, and Maternal Health as within their scope of practice.
Infertility, Prenatal Care, and Maternal Health
No specific health claims of theirs were cross-checked against the literature.
“Infertility, Prenatal Care, and Maternal Health Clinical Strategies and Treatment Applications”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Mold toxicity can be a major cause of long-standing medication-resistant anxiety and depression.
Mold toxicity can be a major cause of long-standing medication-resistant anxiety and depression
No specific health claims of theirs were cross-checked against the literature.
“Mold toxicity can be a major cause of long-standing medication-resistant anxiety and depression”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure CROHN'S & ULCERATIVE COLITIS.
CROHN'S & ULCERATIVE COLITIS
No specific health claims of theirs were cross-checked against the literature.
“CROHN'S & ULCERATIVE COLITIS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure HASHIMOTO'S THYROIDITIS.
HASHIMOTO'S THYROIDITIS
No specific health claims of theirs were cross-checked against the literature.
“HASHIMOTO'S THYROIDITIS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure IRRITABLE BOWEL SYNDROME (IBS).
IRRITABLE BOWEL SYNDROME (IBS)
No specific health claims of theirs were cross-checked against the literature.
“IRRITABLE BOWEL SYNDROME (IBS)”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure LONG COVID.
LONG COVID
No specific health claims of theirs were cross-checked against the literature.
“LONG COVID”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure OSTEOPOROSIS.
OSTEOPOROSIS
No specific health claims of theirs were cross-checked against the literature.
“OSTEOPOROSIS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure RHEUMATOID ARTHRITIS.
RHEUMATOID ARTHRITIS
No specific health claims of theirs were cross-checked against the literature.
“RHEUMATOID ARTHRITIS”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure SIBO.
SIBO
No specific health claims of theirs were cross-checked against the literature.
“SIBO”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Long Covid Symptom: Severe Anxiety and Panic Attacks.
Long Covid Symptom: Severe Anxiety and Panic Attacks
No specific health claims of theirs were cross-checked against the literature.
“Long Covid Symptom: Severe Anxiety and Panic Attacks”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure ANXIETY AND DEPRESSION TESTING.
ANXIETY AND DEPRESSION TESTING
No specific health claims of theirs were cross-checked against the literature.
“ANXIETY AND DEPRESSION TESTING”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure AUTOIMMUNE DISEASE TESTING.
AUTOIMMUNE DISEASE TESTING
- Supports
- No high-quality evidence in the provided index papers supports the standalone claim "Autoimmune Disease" because the indexed items are unrelated to autoimmune disease as a causal or diagnostic assertion. The only autoimmune-related indexed item is a review/decision record for a meta-analysis on parental autoimmune diseases and offspring allergic disease, but the index list does not include the actual peer-reviewed meta-analysis results, so it cannot be used to support the influencer’s claim directly. [5]
- Contradicts
- The claim is too vague to assess as written and does not make a testable medical statement. The provided index papers do not address autoimmune disease generally, and one indexed guideline concerns community-acquired pneumonia, which is unrelated to autoimmune disease . [5] Because the listed sources are not the underlying autoimmune meta-analysis but only editorial/review records, they provide no substantive evidentiary support for a broad autoimmune-disease claim.
- Mainstream view
- Autoimmune disease is a broad category of conditions in which the immune system targets the body’s own tissues; assessing any specific influencer claim requires a precise statement about a disease, mechanism, risk factor, or treatment. As written, the claim is not specific enough for evidence-based validation, and the supplied sources do not establish or refute any particular autoimmune-disease claim. [5]
“AUTOIMMUNE DISEASE TESTING”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure AUTOIMMUNE INFLAMMATION & NEUROLOGICAL TESTING.
AUTOIMMUNE INFLAMMATION & NEUROLOGICAL TESTING
No specific health claims of theirs were cross-checked against the literature.
“AUTOIMMUNE INFLAMMATION & NEUROLOGICAL TESTING”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Dr. Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Anxiety & Depression.
Anxiety & Depression
No specific health claims of theirs were cross-checked against the literature.
“Anxiety & Depression”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Manipulation
transcript · cited
The page opens with chronic illness, mystery symptoms, and poor conventional care, then routes people into remote consults, testing, and custom treatment plans. That is classic attention capture feeding a paid intake funnel. Likely motive: Convert worried readers into paid international consults
“We see patients worldwide!”
transcript · cited
The site repeatedly frames advanced testing as necessary to uncover the 'real' drivers of fatigue, mood issues, thyroid problems, autoimmunity, heart disease risk, and gut disease. That sets up lab spending as the gateway product before treatment. Likely motive: Sell higher-margin testing before treatment
“Specialized Testing & Interpretation”
transcript · cited
A long list of biomarkers is bundled into a 'comprehensive' thyroid panel and then linked to Hashimoto's and other thyroid conditions. This is a textbook lab-interpretation upsell with disease-management branding. Likely motive: Drive revenue through repeated testing and interpretation
“comprehensive panel includes - thyroid antibodies, free T3, free T4, TSH, reverse T3, and total T3 and T4”
source material
The page stacks a chiropractic license, IFM functional medicine certification, and 'board-certified' wording to sound broader and more medical than the credential actually is. Functional medicine certification is not a primary medical license. Likely motive: Inflate authority to make non-standard disease claims feel doctor-grade
“board-certified functional medicine practitioner (IFMCP) and a licensed and board-certified Doctor of Chiropractic (DC)”
transcript · cited
This frames the practice as the missing layer above ordinary medicine, which primes readers to trust its broader diagnostic claims. It is a status move as much as a clinical one. Likely motive: Position the practice as indispensable and superior to standard care
“Functional medicine addresses the care gap that exists between modern medicine and the individual”
transcript · cited
The products section is a commerce shelf for supplements and personal care items, and the page explicitly says commissions are earned from purchases through the links. That is a direct monetization layer on top of health recommendations. Likely motive: Earn affiliate commissions from recommended products
“This post may contain affiliate links, meaning I get a commission if you decide to make a purchase through my links, at no cost to you.”
transcript · cited
The page markets a course built around a hard-to-verify, high-anxiety condition and ties it to the practice brand. That turns a complex syndrome into a productized expertise funnel. Likely motive: Sell courses and specialty consulting to worried patients
“Mastering Histamine Intolerance and Mast Cell Activation Syndrome (MCAS): A Complex Illness Specialist’s Guide”
transcript · cited
Patient testimonials are used to imply causation and effectiveness for serious conditions without controlled evidence. This is persuasive marketing, not clinical proof. Likely motive: Use emotional stories to reduce skepticism and increase conversion
“I owe much to Dr. Lum and am honestly not sure if I would have survived had I not had his help during my particular health crisis”
Commerce & grift map
The money flow looks like worry -> remote consult -> specialized lab panels -> interpretation -> supplements and course upsells. The page also adds affiliate commissions on top of its own practice revenue, so the reader can be monetized twice: once as a patient and again as a click-through consumer.
drbrianlum.com
Lab testing
Affiliate program language on page
DUTCH Test
Lab testing
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
DUTCH Test
Lab testing
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
Doc Bro outbound link (live) · Archive pending
DUTCH Test
Lab testing
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
DUTCH Test
Lab testing
Outbound commerce link detected: compensation likelihood assessed from URL patterns.
Supplements pitched
- HealthPUREMEDY Original Healing Ointment
“HEALTHPUREMEDY Original Healing Ointment”
- Floradix Gallexier Herbal Bitters
“FLORADIX Gallexier Herbal Bitters”
- Gaia Herbs Olive Leaf Extract
“GAIA HERBS Olive Leaf Extract”
- Pure Encapsulations O.N.E. Multivitamin
“PURE ENCAPSULATIONS O.N.E. Multivitamin”
- Bulletproof Coconut Charcoal
“BULLETPROOF Coconut Charcoal”
- Gaia Herbs Elderberry Syrup
“GAIA HERBS Elderberry Syrup”
Labs pitched
- Adrenal function testing
“ADRENAL FUNCTION TESTING”
- Anxiety and depression testing
“ANXIETY AND DEPRESSION TESTING”
- Autoimmune disease testing
“AUTOIMMUNE DISEASE TESTING”
- Autoimmune inflammation & neurological testing
“AUTOIMMUNE INFLAMMATION & NEUROLOGICAL TESTING”
- Advanced heart disease risk assessment
“ADVANCED HEART DISEASE RISK ASSESSMENT”
- Advanced metabolic testing
“ADVANCED METABOLIC TESTING”
- Comprehensive thyroid panel
“COMPREHENSIVE THYROID PANEL”
- Comprehensive stool analysis & microbiome testing
“COMPREHENSIVE STOOL ANALYSIS & MICROBIOME TESTING”
- Crohn's and ulcerative colitis functional testing
“CROHN'S AND ULCERATIVE COLITIS FUNCTIONAL TESTING”
- Urine mycotoxin testing
“Urine mycotoxin testing can assess whether mold is a problem for you”
How the money flows
- Affiliate / promo link Affiliate commissions from product recommendations and shopping links on the page. “This post may contain affiliate links, meaning I get a commission if you decide to make a purchase through my links, at no cost to you.”
“This post may contain affiliate links, meaning I get a commission if you decide to make a purchase through my links, at no cost to you.”
- Lab testing referralUndisclosed Revenue from specialized testing, interpretation, and follow-up appointments around broad disease claims.
- Coaching or consult upsellUndisclosed Paid remote consultation practice with free intake pitch and priced follow-ups. “FREE 15 Minute Consultation”
“FREE 15 Minute Consultation”
- Coaching or consult upsellUndisclosed Online functional medicine course tied to MCAS/histamine intolerance. “Mastering Histamine Intolerance and Mast Cell Activation Syndrome (MCAS): A Complex Illness Specialist’s Guide”
“Mastering Histamine Intolerance and Mast Cell Activation Syndrome (MCAS): A Complex Illness Specialist’s Guide”
Store links detected
- SPECIALIZED TESTINGHigh likelihood
“Affiliate program language on page”
- DUTCH CompleteUnknown
- .cls-1{fill:#6196b7;}Unknown
- .cls-1{fill:#6196b7;}Unknown
- .cls-1{fill:#6196b7;}Unknown
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- DUTCH TestBrand
Promoted commerce partner
- HealthPUREMEDY Original Healing OintmentBrand
Named on a surface without a compensation disclosure
- Floradix Gallexier Herbal BittersBrand
Named on a surface without a compensation disclosure
- Gaia Herbs Olive Leaf ExtractBrand
Named on a surface without a compensation disclosure
- Pure Encapsulations O.N.E. MultivitaminBrand
Named on a surface without a compensation disclosure
- Bulletproof Coconut CharcoalBrand
Named on a surface without a compensation disclosure
- Gaia Herbs Elderberry SyrupBrand
Named on a surface without a compensation disclosure
- Adrenal function testingBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DR, DOCTOR, DO, Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor · KS license 01-05584.
Brian Lum presents as a chiropractor with an IFM functional medicine certification and uses that mix to speak like a broad medical authority on systemic disease. The inflation is in the leap from a spine-and-musculoskeletal license to diagnosing and treating autoimmune, endocrine, infectious, psychiatric, and cardiometabolic conditions.
- DC, Doctor of Chiropractic
A state-licensed chiropractic doctorate; it is not an MD/DO license and does not confer general internal-medicine authority.
State chiropractic boards generally limit practice to musculoskeletal/spinal care, with some ancillary diagnostic authority depending on state law, but not broad management of internal medicine, autoimmune disease, endocrinology, psychiatry, or infection.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: low
Kansas licenses chiropractors as practitioners of the healing arts, but their scope is limited to chiropractic methods focused on the spine, musculoskeletal system, and related neuromusculoskeletal conditions, and does not affirmatively authorize independent medical diagnosis or treatment of systemic diseases such as autoimmune, endocrine, infectious, cardiovascular, or psychiatric disorders. Because the provided board webpage text does not include the chiropractic scope statute or regulations, specific authorizing language for managing non-musculoskeletal diseases cannot be confirmed from the cited content.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
24 of 24 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Crohn's and ulcerative colitis Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing Crohn's disease or ulcerative colitis is the diagnosis and management of complex systemic gastrointestinal disease, which is not affirmatively authorized for chiropractors in the limited scope information available and lies outside typical chiropractic musculoskeletal focus. | Outside scope |
| Listed service Autoimmune disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing autoimmune diseases (systemic immune disorders) constitutes medical evaluation and disease management beyond the musculoskeletal-based chiropractic scope and is not affirmatively authorized in the available Kansas chiropractic materials. | Outside scope |
| Listed service Heart disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing heart disease involves cardiovascular medicine and systemic risk management, which are not affirmatively included in chiropractic scope and are outside the neuromusculoskeletal focus. | Outside scope |
| Listed service Lyme and coinfections Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing Lyme disease and related coinfections is infectious disease practice, not affirmatively permitted for chiropractors under the limited Kansas scope information and beyond chiropractic methods. | Outside scope |
| Listed service Mold illness/exposure Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing "mold illness" or systemic effects of mold exposure is environmental and internal medicine, not affirmatively authorized as part of chiropractic practice. | Outside scope |
| Listed service Thyroid conditions Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing thyroid conditions such as hypothyroidism or thyroiditis is endocrine medicine and not affirmatively authorized within Kansas chiropractic scope based on available information. | Outside scope |
| Listed service Depression Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing depression is a mental health/psychiatric diagnosis that goes beyond the musculoskeletal and neuromusculoskeletal focus described for chiropractic practice and is not affirmatively permitted. | Outside scope |
| Listed service PANS & PANDAS Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing PANS/PANDAS involves complex pediatric neuropsychiatric and immunologic assessment, which is not affirmatively authorized for chiropractors under Kansas healing arts guidance. | Outside scope |
| Listed service Infertility, Prenatal Care, and Maternal Health Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Advertising diagnosis or primary management of infertility, prenatal care, and maternal health entails obstetric and reproductive care not affirmatively included in the limited Kansas chiropractic scope information. | Outside scope |
| Mold toxicity can be a major cause of long-standing medication-resistant anxiety and depression Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Making causal claims and implying evaluation of mold toxicity as a medical cause for refractory anxiety and depression suggests systemic diagnostic authority outside the musculoskeletal chiropractic scope. | Outside scope |
| This testing is used for the treatment of Hashimoto's Thyroiditis and other thyroid conditions Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Treating Hashimoto's thyroiditis and other thyroid conditions is endocrine disease management, which is not affirmatively authorized as a chiropractic modality in Kansas. | Outside scope |
| We can test for insulin resistance which is a major problem in diabetes, an inability to easily lose weight, dementia, PCOS, hormone imbalances, and can play a role in anxiety and depression Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Offering testing for insulin resistance tied to diabetes, dementia, PCOS, and psychiatric symptoms implies laboratory and systemic diagnostic authority not affirmatively granted to chiropractors. | Outside scope |
| Listed service CROHN'S & ULCERATIVE COLITIS Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) As with the earlier Crohn's/ulcerative colitis item, labeling these complex gastrointestinal diseases as practice areas implies diagnosis/management beyond chiropractic scope. | Outside scope |
| Listed service HASHIMOTO'S THYROIDITIS Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Identifying Hashimoto's thyroiditis as a diagnostic focus is endocrine medical practice, which is not affirmatively included in Kansas chiropractic scope. | Outside scope |
| Listed service IRRITABLE BOWEL SYNDROME (IBS) Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing IBS is gastrointestinal disease diagnosis, not affirmatively authorized within chiropractic practice as described in the limited Kansas materials. | Outside scope |
| Listed service LONG COVID Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing or managing Long COVID involves systemic infectious and post-viral care, not affirmatively authorized in chiropractic scope. | Outside scope |
| Listed service OSTEOPOROSIS Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing osteoporosis is a systemic metabolic bone disorder evaluation typically requiring imaging and lab interpretation beyond the musculoskeletal adjustment focus and not affirmatively granted to chiropractors. | Outside scope |
| Listed service RHEUMATOID ARTHRITIS Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing rheumatoid arthritis is rheumatologic disease management involving systemic immune pathology outside the affirmatively authorized chiropractic scope. | Outside scope |
| Listed service SIBO Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Diagnosing small intestinal bacterial overgrowth (SIBO) requires gastrointestinal testing and interpretation beyond chiropractic musculoskeletal practice and not affirmatively permitted. | Outside scope |
| Listed service Long Covid Symptom: Severe Anxiety and Panic Attacks Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Framing severe anxiety and panic attacks as Long COVID symptoms and implying evaluation or management of these psychiatric manifestations goes beyond chiropractic scope. | Outside scope |
| Listed service ANXIETY AND DEPRESSION TESTING Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Offering testing specifically for anxiety and depression implies mental health diagnostic authority not affirmatively granted to chiropractors. | Outside scope |
| Listed service AUTOIMMUNE DISEASE TESTING Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service AUTOIMMUNE INFLAMMATION & NEUROLOGICAL TESTING Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Listed service Anxiety & Depression Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
Sources: Kansas State Board of Healing Arts – Home (official), Kansas Board of Healing Arts – Licensing Department (official), Kansas State Board of Healing Arts, Continuing Education (official)
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Olathe, KS. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-24 17:35 UTC. The archive pane loads styles and images from the intake snapshot.
16 licensed-care paths linked for out-of-scope claims.
Disclaimer hypocrisy
The site hides behind a classic liability shield in the footer, then hands out specific diagnostic and treatment claims all over the page. That is the old 'don't sue us' placard stapled onto a full-service medical advice machine.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drbrianlum.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission YwFezXCj9N2w7xfVrD7eJ
Fight disinformation
Log a public thread where Dr. Brian Lum is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Dr. Brian Lum's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/YwFezXCj9N2w7xfVrD7eJ. White-coat charisma isn't evidence.
Full DTMB scan on Dr. Brian Lum: https://drtrustmebro.com/analyze/YwFezXCj9N2w7xfVrD7eJ
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We could not find a public contact email for Dr. Brian Lum. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Dr. Brian Lum, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Dr. Brian Lum. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: zavjCnJ_WnMq1X5wHu4iH
- Wall entry: /influencer/zavjCnJ_WnMq1X5wHu4iH
- Analysis ID: YwFezXCj9N2w7xfVrD7eJ
- Source: https://www.drbrianlum.com
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] What is the optimal biological therapy for moderate to severe ulcerative colitis: a systematic review and network meta-analysis - PubMed
- [2] Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment
- [3] Network meta-analysis on efficacy and safety of different biologics for ...
- [4] Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
- [5] Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
- [6] Colchicine in Pericarditis.
- [7] Blood Transfusion Therapy.
- [8] Chronic coinfections in patients diagnosed with chronic lyme disease: a systematic review.
- [9] Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1
- [10] Human Babesia odocoilei and Bartonella spp. co-infections in the Americas
- [11] Geographical and temporal distribution of babesial infection in Connecticut
- [12] PubMed indexed study
- [13] PubMed indexed study
- [14] Indoor Mold—Important Considerations for Medical Advice to Patients.
- [15] Respiratory and Allergic Health Effects of Dampness, Mold, and Dampness-Related Agents: A Review of the Epidemiologic Evidence
- [16] Indoor mold and Children's health
- [17] Moulds and asthma: time for indoor climate change?